Gossamer Sees Path To Market For Seralutinib After It Fails In Phase III PAH Trial

PH-ILD Trial Enrollment Paused During Data Analysis

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.